Author

Marina Cipullo

HEPATOBILIARY DISORDERS IN INFLAMMATORY BOWEL DISEASE: WHAT COULD BE THE OPTIMAL MANAGEMENT WHEN PRIMARY BILIARY CHOLANGITIS PRECEDES THE ONSET OF CROHN ILEITIS? A SIXTY-SIX YEARS OLD FEMALE PATIENT CASE REPORT
HEPATOBILIARY DISORDERS IN INFLAMMATORY BOWEL DISEASE: WHAT COULD BE THE OPTIMAL MANAGEMENT WHEN PRIMARY BILIARY CHOLANGITIS PRECEDES THE ONSET OF CROHN ILEITIS? A SIXTY-SIX YEARS OLD FEMALE PATIENT CASE REPORT

Marina Cipullo  et al.

EFFECTS OF GUT MICROBIOTA ON ANTITUMOR ACTIVITY IN CHEMOREFRACTORY METASTATIC COLORECTAL CANCER AND NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CETUXIMAB PLUS AVELUMAB
EFFECTS OF GUT MICROBIOTA ON ANTITUMOR ACTIVITY IN CHEMOREFRACTORY METASTATIC COLORECTAL CANCER AND NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CETUXIMAB PLUS AVELUMAB

Marina Cipullo  et al.

SYSTEMIC OXIDATIVE STRESS-UNBALANCE IN PBC PATIENTS: A PRELIMINARY OBSERVATION ON CORRELATION WITH LIVER DISEASE PROGRESSION
SYSTEMIC OXIDATIVE STRESS-UNBALANCE IN PBC PATIENTS: A PRELIMINARY OBSERVATION ON CORRELATION WITH LIVER DISEASE PROGRESSION

Marina Cipullo  et al.

HEPATOBILIARY DISORDERS IN INFLAMMATORY BOWEL DISEASE: WHAT COULD BE THE OPTIMAL MANAGEMENT WHEN PRIMARY BILIARY CHOLANGITIS PRECEDES THE ONSET OF CROHN ILEITIS? A SIXTY-SIX YEARS OLD FEMALE PATIENT CASE REPORT
HEPATOBILIARY DISORDERS IN INFLAMMATORY BOWEL DISEASE: WHAT COULD BE THE OPTIMAL MANAGEMENT WHEN PRIMARY BILIARY CHOLANGITIS PRECEDES THE ONSET OF CROHN ILEITIS? A SIXTY-SIX YEARS OLD FEMALE PATIENT CASE REPORT

INTESTINAL PSEUDO-OBSTRUCTION AS A COMPLICATION OF SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT OF A FORTY-FOUR YEARS OLD MALE PATIENT WITH RECURRENT GI OBSTRUCTIVE SYMPTOMS
INTESTINAL PSEUDO-OBSTRUCTION AS A COMPLICATION OF SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT OF A FORTY-FOUR YEARS OLD MALE PATIENT WITH RECURRENT GI OBSTRUCTIVE SYMPTOMS

Marina Cipullo  et al.

ASSESSMENT OF URINARY VOLATILE ORGANIC COMPOUNDS: A NON-INVASIVE TOOL FOR DISCRIMINATION OF TYPE 2 DIABETES MELLITUS (T2DM) AND METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE (MAFLD)-FREE T2DM
ASSESSMENT OF URINARY VOLATILE ORGANIC COMPOUNDS: A NON-INVASIVE TOOL FOR DISCRIMINATION OF TYPE 2 DIABETES MELLITUS (T2DM) AND METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE (MAFLD)-FREE T2DM

Marina Cipullo  et al.

THE UROTENSIN-II RECEPTOR: A NEW PREDICTIVE MARKER OF STAGING OF ULCERATIVE COLITIS AND THERAPEUTIC RESPONSE TO INTRAVENOUS STEROID ADMINISTRATION
THE UROTENSIN-II RECEPTOR: A NEW PREDICTIVE MARKER OF STAGING OF ULCERATIVE COLITIS AND THERAPEUTIC RESPONSE TO INTRAVENOUS STEROID ADMINISTRATION

Marina Cipullo  et al.

TRAINED IMMUNITY IN LIVER CIRRHOSIS: FROM MOLECULAR MECHANISMS TO PROGNOSIS IMPLICATIONS. A PRELIMINARY OBSERVATION
TRAINED IMMUNITY IN LIVER CIRRHOSIS: FROM MOLECULAR MECHANISMS TO PROGNOSIS IMPLICATIONS. A PRELIMINARY OBSERVATION

Marina Cipullo  et al.

THE INFLUENCE OF SUPERIMPOSED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV-2) LIFESTYLE CHANGES ON METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE (MAFLD) EVOLUTION: A MATTER OF BODY COMPOSITION
THE INFLUENCE OF SUPERIMPOSED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV-2) LIFESTYLE CHANGES ON METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE (MAFLD) EVOLUTION: A MATTER OF BODY COMPOSITION

Marina Cipullo  et al.

A MULTICENTER CLINICAL STUDY ON SARS-COV2 PANDEMIC CONFINEMENT: A FORCED IN VIVO TEST OF SHORT-TERM LIFESTYLE CHANGES AND THE INFLUENCE ON METABOLIC- (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE (MAFLD) EVOLUTION
A MULTICENTER CLINICAL STUDY ON SARS-COV2 PANDEMIC CONFINEMENT: A FORCED IN VIVO TEST OF SHORT-TERM LIFESTYLE CHANGES AND THE INFLUENCE ON METABOLIC- (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE (MAFLD) EVOLUTION

Marina Cipullo  et al.

HEPATOCELLULAR CARCINOMA (HCC) OCCURRENCE IN A LYSOSOMAL ACID LIPASE DEFICIENCY (LALD)-AFFECTED 49-YEARS OLD NON-CIRRHOTIC MALE: HOW TO MANAGE THE MALIGNANCY IN THIS RARE LIVER-DISEASE CONTEXT?
HEPATOCELLULAR CARCINOMA (HCC) OCCURRENCE IN A LYSOSOMAL ACID LIPASE DEFICIENCY (LALD)-AFFECTED 49-YEARS OLD NON-CIRRHOTIC MALE: HOW TO MANAGE THE MALIGNANCY IN THIS RARE LIVER-DISEASE CONTEXT?

Marina Cipullo  et al.

IL-6 INHIBITOR AS PALLIATIVE TREATMENT FOR A 63 YEARS-OLD MALE PATIENT SUFFERING STAUFFER’S SYNDROME-RELATED PARANEOPLASTIC CHOLESTASIS
IL-6 INHIBITOR AS PALLIATIVE TREATMENT FOR A 63 YEARS-OLD MALE PATIENT SUFFERING STAUFFER’S SYNDROME-RELATED PARANEOPLASTIC CHOLESTASIS

Marina Cipullo  et al.

ADVANCED FIBROSIS AND CARDIOVASCULAR RISK PREDICTION IN MAFLD: THE ALPHA-GLUTATHIONE-S-TRANSFERASE (ALPHAGST) AND THE “METABOLIC ABNORMALITIES-AST/PLATELET RATIO- INFLAMMATION-ALPHAGST LEVELS” (MARINA) INDEX AS A NOVEL PREDICTIVE BIOMARKER AND COMPOSITE T
ADVANCED FIBROSIS AND CARDIOVASCULAR RISK PREDICTION IN MAFLD: THE ALPHA-GLUTATHIONE-S-TRANSFERASE (ALPHAGST) AND THE “METABOLIC ABNORMALITIES-AST/PLATELET RATIO- INFLAMMATION-ALPHAGST LEVELS” (MARINA) INDEX AS A NOVEL PREDICTIVE BIOMARKER AND COMPOSITE T

Marina Cipullo  et al.

ENVIRONMENTAL BISPHENOL A EXPOSURE INFLUENCES TRAINED IMMUNITY-RELATED PATHWAYS IN NON-ALCOHOLIC FATTY LIVER DISEASE: A PRELIMINARY OBSERVATION
ENVIRONMENTAL BISPHENOL A EXPOSURE INFLUENCES TRAINED IMMUNITY-RELATED PATHWAYS IN NON-ALCOHOLIC FATTY LIVER DISEASE: A PRELIMINARY OBSERVATION

Marina Cipullo  et al.

Item 1 - 14 / 14
1